Telo Genomics Corp.: Telo Genomics Forms World-Class Multipl

Toronto, Ontario--(Newsfile Corp. - December 8, 2022) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "TELO") is pleased to announce the formation of a multiple myeloma advisory board

Related Keywords

California , United States , West Hollywood , Canada , Toronto , Ontario , Barcelona , Comunidad Autonoma De Cataluna , Spain , American , Canadian , Hugh Rogers , Elisabet Manasanchcurrently , Elisabet Manasanch , Shaji Kumar , Jamesr Berenson , James Berenson , Richard Bender , Kenneth Anderson , Shaji Kumaris , Mars Centre , Md Inc , Cancer Center Clinical Trials Office , Jerome Lipper Multiple Myeloma Center , American Society Of Hematology , Myeloma Steering Committee , Kenneth Andersonis Program , International Myeloma , Clinical Research , International Myeloma Foundation , College Of Medicine , Venture Exchange , Regulation Services Provider , Division Of Hematology At Mayo Clinic , University Of Barcelona , National Institutes Of Health , Md Anderson Cancer Centre , Harvard Medical School , Newsfile Corp , Myeloma Precursor Disease Program , Telo Genomics Corp , Lebow Institute For Myeloma Therapeutics , Myeloma Tissue Bank , Duke University , American Society , New Orleans , Kenneth Andersonis Program Director , Lebow Institute , Myeloma Therapeutics , Dana Farber Cancer , Mayo Clinic , Medical Director , Principal Investigator , Myeloma Moon Shot , Cancer Centre , Scientific Director , Scientific Boards , Multiple Myeloma Research Foundation , National Institutes , Scientific Review , Clinical Oncology Study , Telo Genomics , South Tower , Atelo , Genomics , Orp , Eforms , World , Glass , Multiple , Myeloma , Advisory , Board , Preparation , Society , Hematology , Nnual , Meeting ,